Dr JMA Hannan earned a PhD in Pharmacology from University of Ulster, UK. He started his research career as Research Officer at the Department of Pharmacology, Research Division, BIRDEM, Dhaka, Bangladesh. He is the founder Chairman of the Department of Pharmacy, North South University, Dhaka currently working as Professor and Head of the Department of Pharmacy in the Independent University, Bangladesh (IUB), Dhaka. He has over 20 years of teaching and research experiences with 76 full publications and 93 abstracts to his credit. He published a textbook on ‘Medical and Pharmaceutical Statistics’.
Dr. Stanley Schwartz is an Affiliate of the Main Line Health System, and an Emeritus Associate Professor of Medicine at the University of Pennsylvania, currently in a private practice in Ardmore, Pa. Dr. Schwartz received his MD in 1973 from the University of Chicago in Chicago, Illinois. He then completed his residency at the University of Pennsylvania, followed by a fellowship in endocrinology and metabolism at the University of Chicago. Dr. Schwartz actively lectures nationally, as well as internationally, about diabetes and its treatment. In the past 7 years he has been a CME speaker in Turks/Caicos, Istanbul, Switzerland , Belgium, Tunisia ,Spain , 11 cities in China, Philippines x4 (Philippine AACE, Philippine Endo. Societyx2, China Hospital ), Israel, Singapore, Korea , and Ireland, and AACE 2011/2014, ADA 2014-2015. He has authored numerous articles in peer-reviewed scientific journals and has been a lead or co-investigator for many clinical trials (DCCT-EDIC, LOOK AHEAD). He has created a call for minimizing hypoglycemia ( predicting a ~50% in hospitals using incretins, and minimizing insulin use in ‘Type 2 ‘ DM. He has proposed a New Classification and Unified Pathophysiologic Construct for All Diabetes and presented it in Jerusalem, at ADA 2014 and ADA/JDRF symposium 2015 and now published in Diabetes Care, and Trends in Endocrinology. Since leaving Penn, he has received an R-01 from the NIH for studying the Genes related to LADA (with 2 articles published), written 3 book chapters, had posters at 2012 AACE, ADA and EASD in 2014 and 2015), has had ~28 peer-reviewed article’s published (incretins in Hospital, hypoglycemia, a critique of ADA DM guideline, incretins in NODAT, weight reduction in DM, the incretin story), and most recently A Unified Pathophysiologic Construct of DM and its Complications.. He is an author of the Self-Assessment Program of the American Diabetes Assoc (2007 and 2008) , the 2009/2010 AACE Diabetes Guidelines, and slide modules for primary care for AACE, 2011 and 2013, and Diabetes in Control 2013-2018. He is a member or fellow of international, national, and local professional societies including an Overseas Fellow of the Royal Society of Medicine (London), European Association for the Study of Diabetes (EASD), the International Diabetes Federation (IDF), the American Diabetes Association (ADA), the American Endocrine Society (ES), College of Physicians in Philadelphia, and the American College of Physicians (ACP). He’s been elected by his peers for inclusion in Best Doctors in America® from 1996 to 2018. Though he does some research and teaches a great deal, most of his time is spent caring for patients.
M V Raghavendra Rao, PhD, worked as Professor of microbiology, parasitology, immunology and Epidemiology in many universities in India, China, Nepal, Libya, and Philippines. Currently, he is working at Avalon University School of Medicine, Curacao, Netherland Antilles. He has more than 40 years of teaching and research experience. He supervised 3 students for PhD, and 8 students for MPhil. He authored 18 text books. Three universities appointed him as their advisor and 3 universities acknowledged him with fellowships.
Dr. Mahir Jallo, Faculty in the Canadian Academy of Natural Health – Canada. He is a Clinical Professor of Medicine & Senior Consultant, Internal Medicine - Diabetes & Endocrinology in Gulf Medical University – UAE. Granted his MB,ChB from Mosul Medical College in IRAQ, his postgraduate Board Certification in Internal Medicine CABM from the Arab Board, his Fellowship of American College of Endocrinology FACE. He joined the JCI Accredited GMCHRC –Thumbay Hospital in 2004 establishing the Diabetes & Endocrinology care in the hospital. He was an Affiliated Faculty in the Department of Medicine, Mosul Medical College & Department of Clinical Pharmacy, Mosul College of Pharmacy – in IRAQ till 2004. In his record active participation & speaker invitation in many National & International conferences & CME programs. Organizer of the annual GMU Diabetes & Endocrinology Conference since 2012. Editor In Chief: Diabetes Digest from Iraq, Editorial Board Member & reviewer for many international Diabetes & Endocrinology journals, with many publications in medical periodicals and medical conferences abstract. Active Principle Investigator in many National & International Clinical studies. Member of many national & international medical societies & associations, AACE, EASD, ISPAD, ESE & European Atherosclerosis Society. Awarded twice A Special Honor & Award in recognition of the exemplary achievements in the field of Internal Medicine & Endocrinology and for the invaluable service to the community.
Dr. Schwartz actively lectures nationally, as well as internationally, about diabetes and its treatment.
Giuseppe Mancia is Emeritus Professor of Medicine at the University of Milano-Bicocca, Director of the Center of Epidemiology and Clinical Trials of the IRCSS Istituto Auxologico Italiano and President of the Hypertension Foundation of the European Society of Hypertension (ESH). His research addresses clinical and basic aspects of hypertension,metabolic abnormalities and cardiovascular diseases. He is past-President of the International Society of Hypertension (ISH), the ESH, the European Society of Clinical Investigation, the Italian Society of Hypertension, the Working Group on Hypertension and the Heart of the European Society of Cardiology (ESC) and the 2003, 2007, 2009 and 2013 ESH/ESC Guidelines Committee on Hypertension. Professor Mancia has received many international and national research awards including the Heymans Award (International Pharmacology Society), Wright Award (Australian High Blood Pressure Council), Volhard and Tigersted Awards (ISH), Folkow Award (ESH), International Recordati Prize and Invernizzi Prize for Medicine. He has received several honorary professorships and degrees Honoris Causa from several Universities, and is Honorary Member of many international Scientific Societies. He has published more than 1500 papers in peer-reviewed Journals and edited or authored more than 20 books on hypertension, cardiovascular and metabolic diseases. He is in the list of the "highly cited" of ISI (Philadelphia). His papers have received more than 81.000 citations with a H-index of 125.
ISHWARLAL JIALAL graduated with the equivalent of an MD, PhD (MB.CH.B, MD) from the University of Natal Medical School, Natal, South Africa, and thereafter undertook fellowships at the Joslin Diabetes Center, Harvard Medical School, and in the Division of Endocrinology, Metabolism and Nutrition at the University of Washington in Seattle. He then joined the faculty of the University of Texas Southwestern Medical Center at Dallas in 1988 as Assistant Professor and became Professor of Internal Medicine and Pathology with tenure in 1997. He was Director of the Division of Clinical Biochemistry and Human Metabolism and was the first hold of the C. Vincent Prothro Chair in Human Nutrition Research. He then joined UC Davis Medical Center as the first holder of Robert E. Stowell Endowed Chair in Experimental Pathology, Director of the Laboratory for Atherosclerosis and Metabolic Research. On his retirement in 2016 he was Distinguished Professor of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, at the University of California, Davis, Medical Center and Staff Endocrinologist at the VA Medical Center, Sacramento.He is presently Professor of Physiology, Metabolism and Pathology at California Northstate university, College of Medicine and Staff Endocrinologist at the VA Medical Center, Mather, CA To date, he has published over 506 original papers and invited reviews in the areas of diabetes, atherosclerosis, lipid metabolism, nutrition and vascular biology and has a H-Index of 73. He has received numerous awards for his research and has served on Editorial Boards of numerous journals including the American Journal of Clinical Nutrition, Journal of Molecular and Cellular Cardiology, Journal of Diabetes and Its Complications, and Journal of Clinical Endocrinology and Metabolism. Dr. Jialal served as Section Editor of AJCP for Clinical Chemistry, Associate Editor , Atherosclerosis, and Editor-in-Chief of Metabolic Syndrome & Related Disorders. He also has a long standing interest in hyperlipidemia and diabetes. His major research interest is in the role of inflammation in atherosclerosis, metabolic syndrome, and understanding the pathobiology of diabetic vasculopathies. His research has been funded over the years by the National Institutes of Health (NIH), American Diabetes Association, Juvenile Diabetes Research Foundation, and American Heart Association. He serves on the Grant Review Panels of the ADA and JDRF, as well as the National Institutes of Health. Dr. Jialal has received numerous awards for his work including the VERIS Award for Nutrition Research; the Centrum Center Science for Nutrition Award, American Society of Nutritional Sciences; the International Hermes Prize for Vitamin Research; the Bennie Zak Award for Outstanding Research, Lipids and Lipoproteins Division, AACC; the Grace Goldsmith Award from the American College of Nutrition; the NIH Mid-Career Investigator Award in Patient Oriented Research, the Distinguished Scientist Award from the National Academy of Clinical Biochemistry, Recipient of the Outstanding Contributions to Clinical Chemistry in a Selected Area of Research Award of the American Association for Clinical Chemistry, the Linus Pauling Award, American College for Advancement in Medicine; Philip Levine Award, American Society of Clinical Pathology, Cooper Award, Lipoprotein and Vascular Diseases Division, AACC, Joliff Award, Division of Clinical and Diagnostic Immunology, AACC and the Garry-Labbe Award for his outstanding contributions in Nutrition , AACC and Diplomate, American Board of Clinical Lipidology . He has been listed Best Doctors in America for 8 years .He has been recipient of the Pathology Teaching Award from the residents at both UT Southwestern and UCDMC.
Educated at Oxford University, Dr. David Jenkins is currently a Professor in both the Departments of Nutritional Sciences and Medicine, Faculty of Medicine, University of Toronto, a Staff Physician in the Division of Endocrinology and Metabolism, the Director of the Clinical Nutrition and Risk Factor Modification Center, and a Scientist in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital. He has served on committees in Canada and the United States that have formulated nutritional guidelines for the treatment of diabetes and recommendations for fibre and macronutrient intake (fat protein and carbohydrates) for the general population (including the Dietary Reference intake or DRIs) under the joint United States-Canada DRI system (RDAs) of the National Academy of Sciences (Washington, DC). He led the team that first defined and explored the concept of the glycemic index of foods. He was the first to demonstrate the breadth of metabolic effects of viscous soluble fiber (as found in fruit, certain beans, oats barley) on blood glucose and cholesterol lowering of relevance to prevention and treatment of diabetes and heart disease. His studies on combining cholesterol lowering food components (dietary portfolio) have been recognized as creating an effective dietary alternative to drug therapy (statins) for lower risk people. In an important study, he compared a dietary portfolio with all food provided with a statin in the same people and demonstrated that the effects of both were comparable. The dietary portfolio, on the basis of this and other studies including a major cross Canada real world study, was the only dietary approach referenced in 2004 Guidelines update of the US National Cholesterol Education Program (ATP III) and recommended in the Canadian Cardiovascular Society (CCS) guidelines for 2012 and the European Atherosclerosis Society consensus statement (2015). He has received many National and International awards in recognition of his contribution to nutrition research. He believes in the value of plant based diets, and that a major effort is required to mount large studies to determine the extent of their health benefits. He also believes that diets have to be environmentally sustainable.
Dr. Ian James Martins is an Editor/Reveiwer for Open Acess Pub/MDPI journals and various other international journals. Advisory Board Member for Photon Journal. Fellow of International Agency for Standards and Ratings (IASR). Conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. Chief Editor for International Journal of Diabetes Research (2014-2018), Research and Reviews: Neuroscience (2016-2018) and Journal of Diabetes and Clinical Studies (2017-2018). BIT Member (BIT Congress. Inc) with an H-index of 64, (ResearchGate STATs (27), Scopus Author ID: 7103152779/Mendeley STATS (21), UWA Research Repository (16). Scientist for The Science Advisory Board (USA) and an Academic with Academia.edu. The citations past 27 years have accumulated to >4584. Ian James Martins - Semantic Scholar https://www.semanticscholar.org/author/Ian-James-Martins/5258067. Semantic Scholar profile for Ian James Martins, with fewer than 50 highly influential citations RESEARCHGATE ANALYSIS: Ian J Martins | Ph D | Centre of Excellence for Alzheimer's Disease ...https://www.researchgate.net/profile/Ian_Martins2 under Ian James Martins’ name places publication RG score (> 96%) of international SCIENTISTS. ORCID CONNECTING RESEARCHER: Editorial Team www.macrothink.org/journal/index.php/jfs/about/editorialTeamBio/13511 Editorial Team. Ian James Martins. Ian James Martins Mail · http://orcid.org/0000-0002-2390-1501. Edith Cowan University, Australia. Prestigious Recognition of Lifetime Membership by International Agency for Standards and Ratings as Fellow for Diabetes, Medical Science (Nutrition). Winner (World Academic Championship -2017) in Diabetes and Medical Science (Nutrition). Certificates from various international conferences have been received in relation to anti-aging, health and disease. Keynote addresses at, Biomedicine 2018 (Osaka, Japan), Global Experts Meeting on Diabetes, Hypertension, Metabolic Syndrome 2018 (Melbourne, Australia), Immunology World 2018 (Amsterdam, Netherlands), Laboratory Medicine 2018 (Berlin, Germany), Innovate Pharma 2017 (Sydney, Australia), Innovate Neurology 2017(Sydney, Australia) World Diabetes and Endocrinology Summit-2017 (Dubai), Pharmacology and Ethnopharmacology 2016 (Chicago, USA) and AGHC 2016 (1st Plenary Speaker, Kaohsiung, Taiwan). Chair/Co-chair Sessions on Laboratory management, Cytogenetics, Clinical Microbiology, Diagnostic Laboratory Medicine etc, 13th Interantional Conference on Laboratory Medicine and Pathology, Berlin, Germany, June 25-26, 2018, Chairing Sessions on Vaccinology, Immunopathology, Immunotherapy, Immune Proteomics, Cancer and Tumour Oncology, 7th World Congress on Immunology, Amsterdam, Netherlands, April 19-20, 2018, Chair, Pipeline 1: Biotherapeutics for Diseases, Bit's 2nd International Congress of Biotherapy-2018 (Programme Committee Member), Chair, Innovate Conferences 2017, Chair/Co-Chair at congress World Gene Convention-2016 (Shanghai, China, Pharmacology and Ethanopharmacology 2016 (Chicago, USA), Annual World Congress of Diabetes-2014 (Haikou, China), World Gene Convention-2014 (Haikou, China). Research Activity Statistics have been provided by Publons with comparison to other researchers. Ian James Martins is now in the 98th percentile as assessed for Publons users by merit. Dr Ian Martins is a reviewer for approx. 47 journals over the past 5 years.
Anti-Aging Genes, Appetite, Environment, Nutrition, Senescence. IMPACT OF PREVIOUS RESEARCH TO THE FIELD OF MEDICINE AND LABORATORY TECHNOLOGY THAT MAY AVOID INADVERTENT ERRORS AND MAY TRANSLATE TO COMMERCIALISATION OF MEDICAL RESEARCH THAT DETERMINE CRITICAL HEATLH OUTCOMES. Development of a BLOOD TEST has been of critical interest to the QUALITY CONTROL of plasma/sera samples for metabolic disease with relevance to diabetes and neurodegenerative diseases.
Gerald C. Hsu received an honorable PhD in mathematics and majored in engineering at MIT. He attended different universities over 17 years and studied 7 academic disciplines. He has spent 20,000 hours in T2D research. First, he studied 6 metabolic diseases and food nutrition during 2010-2013, then conducted his own diabetes research during 2014-2018. His approach is a “quantitative medicine” based on mathematics, physics, optical and electronics physics, engineering modeling, signal processing, computer science, big data analytics, statistics, machine learning, and AI also known as “math-physical medicine”. His main focus is on preventive medicine using prediction tools. He believes that the better the prediction, the more control you have.
Risk Reduction of diabetic complications